Business Description
PEPTONIC medical AB
ISIN : SE0005962206
Total Employee Number:
2Compare
Compare
Traded in other countries / regions
PMED.Sweden28L.Germany IPO Date
2021-05-10Description
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | -0.39 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -7.59 | |||||
Beneish M-Score | -0.77 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -75.5 | |||||
3-Year EBITDA Growth Rate | 71.5 | |||||
3-Year EPS without NRI Growth Rate | 67.3 | |||||
3-Year FCF Growth Rate | 68.5 | |||||
3-Year Book Growth Rate | -65.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 44.24 | |||||
14-Day RSI | 46.13 | |||||
6-1 Month Momentum % | 900 | |||||
12-1 Month Momentum % | 900 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.85 | |||||
Quick Ratio | 0.4 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 528.05 | |||||
Days Payable | 461.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -162.8 | |||||
Shareholder Yield % | -5.64 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.04 | |||||
Operating Margin % | -122.25 | |||||
Net Margin % | -146.1 | |||||
EBITDA Margin % | -80.5 | |||||
FCF Margin % | -125.77 | |||||
OCF Margin % | -125.15 | |||||
ROE % | -45.16 | |||||
ROA % | -29.76 | |||||
ROIC % | -23.89 | |||||
3-Year ROIIC % | -149.6 | |||||
ROC (Joel Greenblatt) % | -5133.45 | |||||
ROCE % | -37.43 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.4 | |||||
PB Ratio | 0.7 | |||||
EV-to-EBIT | -2.79 | |||||
EV-to-EBITDA | -4.19 | |||||
EV-to-Revenue | 3.38 | |||||
EV-to-FCF | -2.69 | |||||
Earnings Yield (Greenblatt) % | -35.84 | |||||
FCF Yield % | -46.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PEPTONIC medical AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.296 | ||
| EPS (TTM) (€) | - | ||
| Beta | 102.6055 | ||
| 3-Year Sharpe Ratio | 0.56 | ||
| 3-Year Sortino Ratio | 31.53 | ||
| Volatility % | 7908.43 | ||
| 14-Day RSI | 46.13 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 0.0002 | ||
| 12-1 Month Momentum % | 900 | ||
| 52-Week Range (€) | 0.00002 - 0.0016 | ||
| Shares Outstanding (Mil) | 27,580.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PEPTONIC medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PEPTONIC medical AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-10 | In 126 days | ||
| Second quarter earnings results for 2026 | 2026-08-19 | In 43 days | ||
| General meeting for 2026 | 2026-06-24 10:00 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-06-03 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-27 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-27 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-06 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-13 | 0.00 (+0.00%) | ||
| General meeting for 2025 | 2025-06-26 10:00 | 0.00 (+0.00%) | ||
| Annual report for 2024 | 2025-06-05 | 0.00 (+0.00%) |
Show
Entries
PEPTONIC medical AB Frequently Asked Questions
What is PEPTONIC medical AB(FRA:28L)'s stock price today?
The current price of FRA:28L is €0.00. The 52 week high of FRA:28L is €0.00 and 52 week low is €0.00.
When is next earnings date of PEPTONIC medical AB(FRA:28L)?
The next earnings date of PEPTONIC medical AB(FRA:28L) is 2026-08-19.
Does PEPTONIC medical AB(FRA:28L) pay dividends? If so, how much?
PEPTONIC medical AB(FRA:28L) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on PEPTONIC medical AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers